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Introduction
Portugal is the European country with the highest frequency of HIV-2 infection, which is mainly
concentrated in West Africa. The cumulative number of notified HIV-2 infections in Portugal
was 1813 by the end of December 2008. To better characterize the dynamics of HIV-2 infection
in the country and to obtain data that may be of use in the prevention of the spread of HIV-2,
we evaluated a large pooled sample of patients.
Patients and methods
Five Portuguese hospitals provided data on HIV-2-infected patients from 1984 to the end of
2007. Data concerning demographic characteristics and clinical variables were extracted. Patients
were stratified according to date of diagnosis in approximately 5-year categories.
Results
The sample included 442 patients, accounting for 37% of all HIV-2 infections notified in
Portugal during that period. HIV-2-infected patients showed clearly different characteristics
according to the period of diagnosis. Until 2000, the majority of HIV-2-infected patients were
Portuguese-born males living in the north of the country. From 2000 to 2007, most of the
patients diagnosed with HIV-2 infection had a West African origin, were predominantly female
and were living in the capital, Lisbon. The average age at diagnosis and loss to follow-up
significantly increased over time.
Conclusion
HIV-2 infection has been documented in Portugal since the early 1980s and its epidemiology
appears to reflect changes in population movement. These include the movements of soldiers
and repatriates from African territories during the independence wars and, later, migration and
mobility from high-endemicity areas. The findings of this study stress the importance of
promoting migrant-sensitive health care.
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Introduction
There are two types of HIV, HIV-1 and HIV-2, and both
entered the human population as a result of zoonotic
transmission [1]. However, HIV-2 infection differs from
HIV-1 infection in many respects. Although the modes of
transmission are the same as for HIV-1, the frequency of
transmission is lower; the rates of sexual and vertical
transmission are around 5–9 times and 10–20 times lower,
respectively, than for HIV-1 [2,3]. HIV-2-infected patients
usually exhibit a slower disease progression and a higher
proportion are long-term nonprogressors [4–6]. Experience
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with antiretroviral therapy is limited; when to start and
which antiretroviral regimen to choose are still poorly
defined. The natural resistance of HIV-2 to nonnucleoside
reverse transcriptase inhibitors and the absence of a gold
standard method for quantification of plasma HIV-2 RNA
are other important limitations in the clinical management
of HIV-2-infected patients [7–9].
HIV-2 is not considered a global public health problem:
while HIV-1 has spread globally, HIV-2 has remained
mainly concentrated in West Africa and to a much lesser
extent in Europe (primarily Portugal and France) [10,11].
However, HIV-2 infection provides a unique opportunity to
study the pathogenesis of HIV infection in humans, and
valuable insights can be gained into HIV-1 from studies of
HIV-2 [6]. Further, HIV-2 infection is an example of the
impact of population mobility on the epidemiology of an
infectious disease. In an increasingly globalized world,
migration and population mobility will continue to chal-
lenge national disease prevention programmes and to
demand new approaches as far as health services planning
is concerned [12,13].
Portugal has one of the highest estimated incidence
levels of HIV infection in Western Europe, with the epi-
demic having mainly been driven by injecting drug use.
During the last decade, however, sexual transmission has
been reported as the predominant mode of transmission.
Also, recently a clear decline was observed in both the
number of reported AIDS cases (new cases halved from 961
in 2003 to 433 in 2009) and AIDS mortality (from 1000
deaths in 2001 to 708 in 2008) [14]. Although >95% of
ever-notified HIV cases were HIV-1, Portugal is the Euro-
pean country with the highest prevalence of HIV-2 infec-
tion. Further, regions historically linked to Portugal, such
as Angola, Mozambique, India and Brazil, have a higher
frequency of HIV-2 infection than other countries [10,11].
Since 1989, virus subtyping has been performed routinely
in Portugal. HIV (type 1 or 2) diagnoses were reported to a
national surveillance department on a voluntary basis until
2005, when notification became mandatory. Nonetheless,
delays in reporting are often long and information con-
cerning clinical variables is scarce. The cumulative number
of notified HIV-2 infections was 1813 as of December 2008.
In the early 1990s, HIV-2 infection accounted for approxi-
mately 10% of the annually diagnosed AIDS cases, while
it decreased to 2.6% in 2000 and 2.3% in 2008 [14]. The
epidemiology of HIV-2 in Portugal has been addressed in
three previous studies. The first study, published in 2003,
described data for 218 HIV-2-infected patients gathered
between 1997 and 2002 at a virology laboratory serving
several hospitals in the south of Portugal [15]. Most of the
HIV-2-infected people were from Guinea Bissau and Cape
Verde. By contrast, in that same year, data from a hospital
in the north of Portugal for 132 HIV-2-infected patients
obtained from 1985 to 2003 showed that 60% of the
patients were male and 95% were Caucasian and born in
Portugal, although in 51% of cases direct or indirect rela-
tionships with Africa could be established [16]. More
recently, data from an infectious disease university hospital
in Lisbon for 142 adult patients diagnosed with an HIV-2
infection from 1987 to 2006 were published [17]. Most
patients (70%) were female, 83 (68%) were born in West
Africa, and heterosexual transmission was documented in
84% of the patients. In the present study, we evaluated a
large pooled sample of patients identified in different hos-
pitals located in different regions of the country, using the
same protocol. We aimed to better characterize the dynam-
ics of HIV-2 infection in Portugal by overcoming the pos-
sible biases of local descriptions.
Patients and methods
Eleven Portuguese hospitals, which together represented
two-thirds of all HIV cases ever notified in Portugal, were
invited to provide data for HIV-2-infected patients in their
respective HIV clinics up to 31 December 2007. By the end
of March 2008, five hospitals had contributed to this
project: Hospital São João and Hospital Joaquim Urbano,
located in the north (Porto region) and Hospital Garcia da
Orta, Hospital Santa Maria and Hospital Fernando Fonseca,
located in the south (the Lisbon region). All clinical records
were manually reviewed and data concerning demographic
characteristics (e.g. biological sex and country of origin)
and clinical variables such as age at diagnosis, mode of
transmission, stage at diagnosis, CD4 cell count at diagno-
sis, treatment experience, progression to AIDS and final
outcome (death) were extracted. Stage at diagnosis was
defined as asymptomatic or AIDS, according to the CD4
cell count (defined as <200 cells/mL) or clinical AIDS pres-
entation. Area of residence was extrapolated from the
location of the hospital where the patient was followed.
Data from 442 patients were obtained. This sample
included 37% of all HIV-2 (mono)infections notified in
Portugal as of the end of 2007. Continuous variables are
presented as mean  standard deviation (SD). Categorical
variables are presented as counts and proportions. Patients
were stratified according to date at diagnosis in approxi-
mately 5-year categories. Data were analysed using SPSS
version 18 (SPSS Inc., Chicago, IL, USA). Proportions were
compared using the c2 test and ages were compared by
means of a one-way analysis of variance (ANOVA).
P-values of <0.05 were considered statistically significant.
The ethical committee of Hospital São João approved the
study design in 2007. No specific consent was obtained
from the patients as the data were used anonymously.
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Results
As shown in Table 1, in the sample as a whole there were
similar proportions of male and female patients. Patients
followed in the southern area of the country represented
59% of the sample population. Dual infections (HIV-1 and
HIV-2) accounted for a minority (3.6%) of cases. Around
half of the patients were Portuguese citizens (213; 48.2%).
Guinea Bissau, Cape Verde and Angola were the countries
of origin of 33.5, 7.9 and 2.5% of the patients, respectively.
The mode of transmission was mainly reported as hetero-
sexual (260; 58.8%). Blood transfusions were the route for
HIV-2 transmission in 15.4% of cases, but the proportion of
cases attributed to blood transfusions has been declining
over time. Injecting drug use was the mode of acquisition
in 2.3% of patients and men who have sex with men
accounted for 1.1%. Vertical transmission was rare (0.9%).
The mode of transmission was not specified for 21.5% of
the participants.
The majority of the patients were asymptomatic at diag-
nosis (283; 64.0%). Lymphocyte CD4 cell count at diag-
nosis was available for 62% of the patients. Of these, 62
(22.6%) had a CD4 count <200 cells/mL. At the last
follow-up evaluation, most patients remained treatment-
naïve (200; 45.2%). However, 156 (35.3%) were on anti-
retroviral therapy, 14.5% of whom had experienced at least
two different treatment regimens. During follow-up, at
least 23.7% developed AIDS. By the end of December 2007,
128 (29%) of the patients were alive; 82 (18.6%) had died.
For 232 (52.5%), the outcome was unknown.
HIV-2 infection diagnoses were distributed over time
as follows: 1985 to 1989, 57 patients; 1990 to 1994,
83 patients; 1995 to 1999, 95 patients; 2000 to 2004, 127
patients and 2005 to 2007, 73 patients (Table 2). For seven
patients, the year of diagnosis was not specified. Before
1989, the majority of patients were male (39; 68.4%), had
Portuguese nationality (45; 78.9%) and were living in the
north of the country (44; 77.2%). The mean age at diag-
nosis was 31.0 (14.7) and 37.8 (8.9) years for male and
female patients, respectively. Most patients were infected
through heterosexual intercourse (31; 54.4%), but the pro-
portion of HIV-2 infections attributed to blood transfusions
was high (22; 38.6%). Forty-one individuals (71.9%) were
asymptomatic at the time of diagnosis.
From 1990 to 1994, the numbers of cases of newly
diagnosed HIV-2 infection were nearly equal in men and
women (41 men and 42 women). Heterosexual trans-
mission remained the main transmission route (61.4%),
followed by blood transfusion (31.3%). More than 70% of
cases were diagnosed in the north of the country.
From 1995 to 1999, HIV-2 infection was more frequently
found in female patients (64; 67.4%). Portugal was the
country of birth of 54.7% of individuals. Cases attributed
to transfusions declined to 10.5%, while those attributed
to heterosexual intercourse increased to 65.3%. Three
cases of vertical transmission were diagnosed, while for
17 patients (17.9%) the mode of transmission was not
specified. During this period, 63.2% (60) of the diagnoses
were made in hospitals located in the south of the
country.
From January 2000 to December 2004, 127 additional
patients were identified. Most cases were still among
Table 1 Demographic and clinical characteristics of 442 individuals
with HIV-2 infection; Portugal (1985–2007)
n %
442 100
HIV-2 infected patients 426 96.4
HIV-1+2 infected patients 16 3.6
Hospital
Hospital São João 140 31.7
Hospital Santa Maria 142 32.1
Hospital Fernando Fonseca 64 14.5
Hospital Garcia da Orta 55 12.4
Hospital Joaquim Urbano 41 9.3
Date of diagnosis (years)
1985–1989 57 12.9
1990–1994 83 18.8
1995–1999 95 21.5
2000–2004 127 28.7
2005–2007 72 16.3
Unknown 8 1.8
Sex
Female 248 56.1
Male 192 43.4
Unknown 2 0.4
Country of origin
Portugal 213 48.2
Guinea Bissau 148 33.5
Cape Verde 35 7.9
Angola 11 2.5
Mozambique 2 0.4
Brazil 1 0.2
Unknown 32 7.2
Transmission mode
Heterosexual 260 58.8
Men who have sex with men 5 1.1
Injecting drug use 10 2.3
Vertical 4 0.9
Transfusional 68 15.4
Not specified 95 21.5
Stage at diagnosis
AIDS 98 22.2
Asymptomatic 283 64.0
Not specified 61 13.8
Outcome (until Dec 2007)
Dead 82 18.6
Alive 128 29.0
Unknown 232 52.5
Because of rounding, percentages may add up to over 100.
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female patients (84; 66.1%). The major differences from
the previous periods were the patients’ country of origin
and residence area, with the majority (77; 60.6%) coming
from West African countries and being diagnosed in
Lisbon (100; 78.7%). Heterosexual intercourse remained
the primary mode of HIV-2 acquisition (75; 59.1%) while
blood transfusions almost disappeared as a cause of
infection (6; 4.7%). In 31.5% of cases the route of trans-
mission was not specified. Most patients had no AIDS-
defining illness at diagnosis (80; 63.0%), although the
stage at diagnosis was not possible to ascertain for 20
patients (15.7%). In the last three years of the study
period (2005–2007), 73 additional patients were diag-
nosed with HIV-2 infection: 39 women and 34 men. The
average age at diagnosis was higher than in the previous
periods (43.0 years for women and 48.7 years for men).
West African origin was reported for 64.4% of patients
(47), while 23.3% (17) were Portuguese. More than 80%
of the diagnoses were made at one of the participant
hospitals located in Lisbon. Most patients were infected
heterosexually (39; 53.4%) and only 4.1% through blood
transfusions. No case of vertical transmission was docu-
mented. However, the mode of transmission was not
specified for 30 patients (41.1%).
Discussion
This sample of 442 HIV-2-infected patients is the largest
sample of HIV-2-infected patients ever described. The
sample represents 37% of all HIV-2 (mono)infections noti-
fied in Portugal as of the end of 2007 and includes patients
from hospitals that cover a wide geographical area. The
proportion of cases identified over each time period resem-
bles the pattern observed for notified cases and the sample
is representative of the transmission dynamics of HIV-2 in
the country (Table 2). From 1985 to 2007, HIV-2-infected
patients included in the sample presented distinct charac-
teristics according to the period of diagnosis. Until 2000,
the majority of HIV-2-infected patients were Portuguese-
born men living in the north of the country, but from 2000
to 2007 most patients diagnosed with HIV-2 infection had
a West African origin, were predominantly female and
Table 2 Demographic and clinical characteristics of 442* individuals with HIV-2 infection according to period of diagnosis in Portugal (1985–
2007)
1985–1989 1990–1994 1995–1999 2000–2004 2005–2007
Pn (%) n (%) n (%) n (%) n (%)
HIV-2 diagnosis (sample)* 57 (12.9) 83 (18.8) 95 (21.5) 127 (28.7) 73 (16.5)
HIV-2 diagnosis†
(national notified cases)
123 (10.5) 306 (26.1) 287 (24.5) 315 (26.9) 140 (12.0)
Sex
Female 18 (31.6) 41 (49.4) 64 (67.4) 84 (66.1) 39 (53.4)
Male 39 (68.4) 42 (50.6) 31 (32.6) 43 (33.9) 34 (46.4) < 0.001
Country of origin
Portugal 45 (78.9) 60 (72.3) 52 (54.7) 37 (29.1) 17 (23.3)
West Africa 5 (8.8) 18 (21.7) 32 (33.7) 77 (60.6) 47 (64.4)
Other 0 (0.0) 1 (1.2) 4 (4.2) 5 (3.9) 4 (5.5)
Unknown 7 (12.3) 4 (4.8) 7 (7.4) 8 (6.3) 5 (6.8) < 0.001
Transmission mode
Heterosexual 31 (54.4) 51 (61.4) 62 (65.3) 75 (59.1) 39 (53.4)
Men who have sex with men 0 (0.0) 2 (2.4) 0 (0.0) 3 (2.4) 0 (0.0)
Injecting drug use 1 (1.8) 3 (3.6) 3 (3.2) 2 (1.6) 1 (1.4)
Vertical 0 (0.0) 0 (0.0) 3 (3.2) 1 (0.8) 0 (0.0)
Transfusional 22 (38.6) 26 (31.3) 10 (10.5) 6 (4.7) 3 (4.1)
Not specified 3 (5.3) 1 (1.2) 17 (17.9) 40 (31.5) 30 (41.1) < 0.001
Stage at diagnosis
Asymptomatic 41 (71.9) 57 (68.7) 57 (60.0) 80 (63.0) 46 (63.0)
AIDS 15 (26.3) 19 (22.9) 21 (22.1) 27 (21.2) 15 (20.6)
Unknown 1 (1.8) 7 (8.4) 17 (17.9) 20 (15.7) 12 (16.4) 0.169
Residence area
Porto 44 (77.2) 61 (73.5) 35 (36.8) 27 (21.2) 12 (16.4)
Lisbon 13 (22.8) 22 (26.5) 60 (63.2) 100 (78.7) 61 (83.6) < 0.001
Outcome (December 2007)
Death 29 (50.9) 25 (30.1) 21 (22.1) 4 (3.1) 1 (1.4)
Survival 17 (29.8) 30 (36.1) 23 (24.2) 44 (34.6) 14 (19.2)
Unknown 11 (19.3) 28 (33.7) 51 (53.7) 79 (62.2) 58 (79.5) < 0.001
*Date of diagnosis was unknown for seven (1.8%) of the patients in the sample.
†Only mono-infections are included.
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were living in the capital, further south. To understand
HIV-2 infection trends, one needs to consider the historical
context and the effect of population mobility on virus
migration.
HIV-2 infection spread under particular political and
social circumstances during the independence wars of
former Portuguese territories. In Guinea Bissau, for
example, the demographic history of HIV-2 is characterized
by a period of low endemicity followed by an exponential
increase in the number of infections during the war (1961–
1974). Increased commercial sex, unsafe blood transfusions
and other events occurring in a socially and economically
disrupted country probably facilitated transmission of the
virus [11]. The highest prevalence of HIV-2 infection was
reported two decades ago in Guinea Bissau: the prevalence
was 8% in adults, and reached up to 20% in individuals
over 40 years of age [18]. The estimated incidence of HIV-2
infection in Guinea Bissau is now declining: between 1996
and 2006 the incidence rate for HIV-2 infection was 0.24
per 100 person-years (0.5 per 100 person-years for HIV-1)
[19]. These historical and socioeconomic circumstances
might help to explain why Portugal is the country outside
the African continent with the highest number of HIV-2-
infected patients. However, studies on HIV-2 epidemiology
in Portugal are limited and have provided contradictory
descriptions [15–17]. By investigating a larger sample,
including patients from five hospitals, we have tried to
minimize selection biases.
Important information can be obtained by looking at
epidemiological data over time. The independence wars in
Portuguese colonies during the period 1960–1974 probably
had a role in the introduction of HIV-2 to Portugal. The fact
that most HIV-2-infected patients included in our sample
who were diagnosed before 1990 were male (39; 68.4%),
Portuguese (45; 78.9%) supports this possibility. For more
than 10 years, hundreds of thousands of soldiers were sent
to Africa. Heterosexual transmission was reported for the
majority of cases in the present study, but the importance
of blood transfusions and/or surgical procedures performed
during the war should not be underestimated. The inde-
pendence wars were also responsible for a massive influx
of repatriates (more than 500 000), including women, into
Portugal. From 1990 to 1994, the number of diagnosed
infections increased. The similar characteristics in terms of
nationality (Portuguese) and area of residence (the north of
the country) of most of the persons diagnosed in this period
compared to those diagnosed in the previous period may
reflect the ongoing transmission of HIV-2 after its intro-
duction into the country. Further, the fact that the propor-
tions of male and female individuals diagnosed were
similar supports the hypothesis that transmission from
previously infected male patients (many of them probably
former soldiers) to their female partners took place. The
last 5 years of the 1990s anticipated the change clearly
observed from 2000 onwards, probably as a result of
increased migration from West Africa, reversing previously
described trends.
In 2008, migrants from Guinea Bissau and Cape Verde
represented 18% of the total population of migrants in
Portugal (6 and 12%, respectively) and in the last few years
the number has increased. The geographical distribution of
these migrants is heterogeneous, the majority (68.8%)
living in southern Portugal [20]. Therefore, it is not sur-
prising to find that native Africans living in the capital
(Lisbon) represent the majority of the most recently diag-
nosed cases of HIV-2 infection. In addition, as two large
hospitals located in southern Portugal are not represented
in our sample, this epidemiological change is probably
underestimated. The general area of residence (north/south)
was extrapolated taking into account the hospital where
patients were diagnosed and followed, although some
patients may not have attended a hospital in their area of
residence. Nonetheless, we believe that only a minority
would travel more than 300 km to attend another hospital.
Data from a Portuguese study addressing this issue
revealed that the average distance from a patient’s resi-
dence to a hospital where HIV-infected patients were
admitted was 13 km [21].
Interestingly, there has been over the study period a
steeper increase in age at the time of diagnosis, statistically
significant for men. However, the proportion of patients
presenting with AIDS has not changed substantially. Does
this mean that men are being infected later and tested
earlier in the course of the infection or, on the contrary, are
they being diagnosed at an older age and later but remain-
ing asymptomatic as a result of a slower progression of the
disease? Testing for HIV has been performed routinely for
blood donations since 1985 and recommendations for
screening women before or during pregnancy date back to
1998. Further, there have been campaigns over the last few
decades promoting HIV testing of those with a history
of injecting drug use, unprotected sexual intercourse or
transfusions, particularly in Africa, although information
related to the uptake of testing over time, either patient- or
provider-initiated, is not available. Studies addressing HIV
testing practices and disease progression are needed to
answer these and related questions.
Experience with the treatment of HIV-2-infected patients
on antiretroviral therapy is limited; when to start and
which antiretroviral regimen to choose are still poorly
defined. In our sample, we found that, although the major-
ity of patients were treatment-naïve, the proportion of
patients who had experienced more than two different
treatment regimens (14.5% of those ever treated) highlights
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the need to improve the evidence base for decisions on
which therapy to initiate.
People living with HIV experienced a major change in
survival rates after the introduction of effective treatment
regimens. Whether the same applies to the prognosis of
HIV-2-infected patients is not known. Also, we cannot
infer an effect of the described therapeutic experiences of
the study population on the rate of AIDS progression and
case fatality. By the end of December 2007, at least 18.6%
of the patients had died, 29% were alive and attending
scheduled appointments, but most, 52.5%, were lost to
follow-up. Surprisingly, the majority of patients for whom
no outcome information is available were those diagnosed
in more recent years and therefore those that we would
expect to be attending consultations at the respective
clinics. Moreover, 63.3% of those patients were migrants of
African origin. The reasons underlying such a high number
of losses to follow-up needs further investigation. Social,
economic and cultural factors highlight the need to
develop special approaches for migrant populations and to
promote migrant-sensitive health care.
As the world’s population grows, migration and popu-
lation mobility are likely to increase [12,13]. The incidence
of HIV-2 infection is declining in West Africa but the
increasing influx of migrants will probably maintain HIV-2
in Portugal and other countries. For example, in France,
between January 2003 and June 2006, 186 HIV-2-infected
patients were identified [22]. In Spain, from 1988 to 2006,
a total of 146 HIV-2 infections were reported [23]. Up to
2007, 65 patients with HIV-2 (mono)infection were
included in the Belgium–Luxembourg database [24]. The
majority of HIV-2-infected patients identified in these
countries were from a West African country. Also, the
number of HIV (including HIV-2) infections acquired in
West Africa and diagnosed in England, Wales and Northern
Ireland has risen in recent years [25]. The same trend has
been observed in the USA, where HIV-2 infection is con-
sidered to be rare. From 1985 to 1998, only 79 cases of
HIV-2 infection were reported to the Centers for Disease
Control and Prevention (CDC). However, data from New
York City showed that, between 1 June 2000 and 31
December 2008, 62 more people received a diagnosis of
HIV-2 infection. The majority (60 of 62 individuals) were
born in Africa [26]. This highlights the need to discuss the
impact of migration on national infectious disease epide-
miology, of which HIV-2 is just one example.
Conclusions
HIV-2 infection has been documented in Portugal since the
early 1980s and its epidemiology appears to reflect changes
in population movement. Our study suggests that the intro-
duction of HIV-2 was related to the movements of soldiers
and repatriates from African territories during the wars of
independence and that migration and mobility of people
from high-endemicity areas have, more recently, played a
prominent role in the dynamics of HIV-2 infection. The
creation of a Portuguese cohort of HIV-2-infected patients
would be an important step towards a better understanding
of these descriptive findings.
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